CUE
CUE BIOPHARMA (CUE)
NASDAQ
$24.43+$0.45 (+1.86%)
Price as of Aug 21, 2026 7:30 PM EDT
  • $174.2M
    Market Cap
  • -3.23%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
VANGUARD GROUP INC
114.69%
3.0M
-25,288 (-0.84%)
Dec 31, 2025
BLACKROCK INC.
28.80%
756,736
-1.5M (-196.55%)
Jun 30, 2024
BLACKROCK FUNDING, INC. /DE
24.31%
638,952
+67,977 (+10.64%)
Dec 31, 2024
BLEICHROEDER LP
14.11%
370,682
+370,682 (+100.00%)
Jun 30, 2026
SANDERS MORRIS HARRIS INC.
13.67%
359,113
+53,381 (+14.86%)
Dec 31, 2021
DRIEHAUS CAPITAL MANAGEMENT LLC
11.12%
292,144
+292,144 (+100.00%)
Jun 30, 2026
TWO SIGMA ADVISERS, LLC
8.65%
227,200
+25,200 (+11.09%)
Dec 31, 2021

Current Ownership Distribution

  • Institutions284.1M (79.49%)
  • Mutual Funds67.4M (18.85%)
  • Insiders5.9M (1.66%)
  • Other0 (0.00%)

Insider Transactions

  • 1.66% (5.9M)
    Current InsiderOwnership (%, shares)
  • 1
    Number of InsiderBuying (last 12 months)
  • $153,841.43
    Amount of InsiderBuying (last 12 months)
  • 2
    Number of InsiderSelling (last 12 months)
  • $109.4M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Lin Shao-Lee
Chief Executive Officer
Sell
Aug 13, 2026
$147,451.37
5,423
$27.19
718,830
Ray Sumita
Chief Legal Compliance Officer
Exempt
Aug 13, 2026
$0.00
18,196
$0.00
36,393
Lin Shao-Lee
Chief Executive Officer
Sell
Aug 13, 2026
$66,761.25
2,375
$28.11
716,455
Ray Sumita
Chief Legal Compliance Officer
Exempt
Aug 13, 2026
$0.00
18,196
$0.00
127,374
Lin Shao-Lee
Chief Executive Officer
Sell
Aug 13, 2026
$308,360.80
10,460
$29.48
705,995
Ray Sumita
Chief Legal Compliance Officer
Sell
Aug 13, 2026
$69,988.71
2,383
$29.37
124,991
Ray Sumita
Chief Legal Compliance Officer
Sell
Aug 13, 2026
$195,514.70
6,442
$30.35
118,549
Ray Sumita
Chief Legal Compliance Officer
Sell
Aug 13, 2026
$124.52
4
$31.13
118,545
Lin Shao-Lee
Chief Executive Officer
Exempt
Aug 12, 2026
$0.00
109,179
$0.00
218,358
Lin Shao-Lee
Chief Executive Officer
Exempt
Aug 12, 2026
$0.00
109,179
$0.00
764,253
Lin Shao-Lee
Chief Executive Officer
Sell
Aug 12, 2026
$923,732.75
34,225
$26.99
730,028
Lin Shao-Lee
Chief Executive Officer
Sell
Aug 12, 2026
$160,256.25
5,775
$27.75
724,253
Ahlers James M
Chief Financial Officer
Award
Jul 30, 2026
$0.00
51,000
$0.00
51,000
Ahlers James M
Chief Financial Officer
Award
Jul 30, 2026
$0.00
25,500
$0.00
25,500
Camardo Daniel A.
Award
Jul 09, 2026
$0.00
21,800
$0.00
21,800
Garzone Pamela
Award
Jul 09, 2026
$0.00
21,800
$0.00
21,800
Sarraf Pasha
Award
Jul 09, 2026
$0.00
21,800
$0.00
32,595
Lin Shao-Lee
Chief Executive Officer
Award
Jul 09, 2026
$0.00
327,537
$0.00
327,537
Lin Shao-Lee
Chief Executive Officer
Award
Jul 09, 2026
$0.00
327,537
$0.00
655,074
Baker Daniel G.
CHIEF DEVELOPMENT OFFICER
Award
Apr 09, 2026
$0.00
100,000
$0.00
100,000
Warren Lucinda
CHIEF BUSINESS OFFICER
Award
Apr 09, 2026
$0.00
250,000
$0.00
250,000
Sandercock Colin
SVP, GENERAL COUNSEL
Award
Apr 09, 2026
$0.00
200,000
$0.00
200,000
Verheyen Patrick
Award
Jan 02, 2026
$0.00
24,400
$0.00
24,400
Morich Frank
Award
Jan 02, 2026
$0.00
24,400
$0.00
24,400
Garzone Pamela
Award
Jan 02, 2026
$0.00
24,400
$0.00
24,400
Sarraf Pasha
Award
Jan 02, 2026
$0.00
24,400
$0.00
24,400
Broadfoot Jill Marie
Award
Jan 02, 2026
$0.00
24,400
$0.00
24,400
Sarraf Pasha
Buy
Dec 30, 2025
$1,308.45
4,229
$0.31
4,229
Sarraf Pasha
Buy
Dec 30, 2025
$23,167.54
77,148
$0.30
81,377
Sarraf Pasha
Buy
Dec 30, 2025
$27,596.98
86,947
$0.32
168,324